NCT01482247View on ClinicalTrials.gov

L-Arginine, Vascular Response and Mechanisms

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
HypertensionDiabetes
Interventions
DIETARY_SUPPLEMENT

L-Arginine

Dietary Supplement

DIETARY_SUPPLEMENT

Placebo Supplement

Dietary Supplement

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT01482247 - L-Arginine, Vascular Response and Mechanisms | Biotech Hunter | Biotech Hunter